ストックスクリーナーアプリを入手
27.49
1.01%
-0.28
アフターアワーズ：
27.48
-0.010
-0.04%
前日終値:
$27.77
開ける：
$27.7
24時間の取引高:
123.62K
Relative Volume:
4.49
時価総額：
$1.81B
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+1.63%
1か月 パフォーマンス:
+0.00%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$27.44
$27.99
1週間の範囲:
$26.42
$27.99
52週間の値動き範囲:
$26.42
$28.32
Lakefront Biotherapeutics Nv Adr Stock (LKFT) Company Profile
Compare LKFT vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LKFT
Lakefront Biotherapeutics Nv Adr
|
27.49 | 1.83B | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
434.52 | 110.03B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
638.88 | 67.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
806.46 | 50.76B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
297.45 | 40.12B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
151.56 | 32.68B | 742.00K | -1.37B | -1.07B | -7.0731 |
Lakefront Biotherapeutics Nv Adr (LKFT) 最新ニュース
LKFT Technical Analysis | Trend, Signals & Chart Patterns | LAKEFRONT BIOTHERAPEUTIC-ADR (NASDAQ:LKFT) - ChartMill
LKFT.AS Stock Price, Quote & Chart | LAKEFRONT BIOTHERAPEUTICS (AMS:LKFT) - ChartMill
LKFT Stock Chart | LAKEFRONT BIOTHERAPEUTIC-ADR (NASDAQ:LKFT) - ChartMill
What is the current Price Target and Forecast for Lakefront BiotherapeuticsSponsored ADR (LKFT) - Zacks Investment Research
Earnings call transcript: Galapagos NV sees 91% revenue drop in Q1 2026 - Investing.com
LKFT: Lakefront BiotherapeuticsSponsored ADRCash Flow Statements - Zacks Investment Research
LKFT : Lakefront BiotherapeuticsSponsored Adr Key Company Details - Zacks Investment Research
Lakefront BiotherapeuticsSponsored ADR (LKFT) Return On Equity (TTM) - Zacks Investment Research
Lakefront Biotherapeutics NV Stock Baskets - GuruFocus
Lakefront Biotherapeutics (NASDAQ: GLPG) outlines ADR deposit terms - Stock Titan
LKFT Stock Price and Chart — NASDAQ:LKFT - TradingView
Earnings call transcript: Galapagos Q1 2026 beats EPS, revenue falls short - Investing.com
Galapagos (GLPG) posts Q1 2026 profit and commits up to €790M to Ouro deal - Stock Titan
Invesco Nasdaq Biotechnology ETF Holdings - Quiver Quantitative
symbol__ Stock Quote Price and Forecast - CNN
ActivePassive International Equity ETF Holdings - Quiver Quantitative
Lakefront Biotherapeutics Nv Adr (LKFT) 財務データ
Lakefront Biotherapeutics Nv Adr (LKFT) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
2.98%
1.33%
大文字化:
|
ボリューム (24 時間):